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Edited by Jesus AvilaAbstract We report the amyloid-like properties of Escherichia
coli transthyretin-like protein (TLP). TLP is 32% homologous
to human transthyretin (hTTR), and is also tetrameric. In con-
trast to hTTR, TLP does not bind thyroxine. TLP orthologues
are found in several prokaryotes, lower eukaryotes and verte-
brates. TLP carries a signal peptide that targets the protein to
the periplasmic space. We found that TLP and hTTR tetramers
dissociate into monomers under similar conditions, although
TLP monomers have diﬀerent association properties. Like
hTTR, TLP forms aggregates, small ﬁbrillar structures of
8 nm width, and annular structures of 8 nm diameter which pres-
ent amyloid-like properties and are toxic to cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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In almost all vertebrates, transthyretin (TTR) is responsible
for the transport of retinol binding protein in complex with
retinol (vitamin A) and of thyroid hormones – thyroxine
(T4) and 3,3 0,5-triiodothyronine (T3). TTR evolved in the cho-
roid plexus of stem reptiles 350 million years ago [1]. Liver
TTR synthesis appears to have originated independently much
later, about 50 million years ago, in the lineage leading to to-
days eutherians, diprotodont marsupials, polyprotodont mar-Abbreviations: TLP, transthyretin-like protein; TTR, transthyretin;
TEM, transmission electron microscopy; Th-T, thioﬂavin-T
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doi:10.1016/j.febslet.2008.07.025supials, birds and ﬁsh [2]. The overall three-dimensional
structure of vertebrate TTR has not changed signiﬁcantly dur-
ing evolution [3]. Amino acid diﬀerences between species lie on
the surface of the molecule. Most changes are located within
the ﬁrst 10 amino acids from the NH2-terminus. There has
been a successive shortening of the 5 0 end of exon 2, resulting
in a shorter and more hydrophilic N-terminal region [4].
The central channel that harbours the thyroid hormone-
binding site is highly conserved in all TTRs [5]. Although
structure has been conserved, the functional properties of
TTR have changed during evolution. The main diﬀerences in-
clude tissues of synthesis (liver and/or choroid plexus) and the
decrease of T3 aﬃnity in favour of T4 [6].
An increasing number of prokaryotes and lower eukaryotes
with sequences homologous to TTR, the transthyretin-like
proteins (TLPs), are emerging since their ﬁrst mention in
1997 by Sonnhammer and Durbin [7] and later in 2000 by
Monaco [8] and Prapunpoj et al. [9].
It has been suggested that TLP could be an ancestor of TTR
[3,10] that arose from a duplication event [11]. Organisms with
a characterized function for TLP protein include: Arabidopsis
thaliana [12]; Bacillus subtilis [13,14]; Escherichia coli [15] and
Salmonella dublin [16]. TLP from A. thaliana was identiﬁed
as a membrane associated protein involved in control of
growth through association with the brassinosteroid-insensi-
tive 1 receptor (BRI1) [12]. Caenorhabditis elegans has two
TLP genes [17]; both genes are transcriptionally regulated dur-
ing development. However, inactivation of TLP expression by
double-stranded (ds) RNA interference yielded no phenotype.
In B. subtilis, however, TLP inactivation resulted in an uricase-
defective phenotype [13] leading to the proposal that TLP was
responsible for the hydrolysis of 5-hydroxyisourate. A similar
role in uric acid metabolism was found for TLP from E. coli
[15], S. dublin [16] and Mus musculus [18].
Eneqvist et al. [17] characterized TLPs from E. coli and C.
elegans. They showed that recombinant TLPs formed tetra-
mers, as does TTR from vertebrates [11]. TLP from E. coli
was reported to be a homotetramer of approximately
52 kDa. In contrast to hTTR, TLP from these organisms did
not bind T4. Furthermore, partial acid denaturation, which
converts hTTR to aggregates and ﬁbrils with amyloid-like
properties, had no eﬀect on E. coli TLP [17].
In this work, we present studies performed with E. coli TLP
that reveal its amyloidogenic potential and its toxicity in cellu-
lar studies.blished by Elsevier B.V. All rights reserved.
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2.1. Physical–chemical characterization of TLP
To study its biochemical and physical properties, E. coli TLP
protein or a FLAG peptide tag derivative was over-expressed
and puriﬁed. TLP was analysed by gel ﬁltration. A protein
peak was identiﬁed that eluted similarly to homotetrameric
hTTR, just ahead of the molecular weight calibration stan-
dard, ovalbumin (43 kDa) (Fig. 1A). This elution pattern sup-
ports a previous report that TLP in its native state is a
homotetrameric protein [17]. The protein sequence of TLP
was veriﬁed by mass spectrometry (see Section 4).
We then compared the dissociation of hTTR and untagged
TLP tetramers. After boiling with or without b-mercap-
toethanol, TLP migrated in SDS–PAGE as a monomer of
approximately 16 kDa (Fig. 1B, lane 1 and data not shown).
Non-heated samples contained both tetramers and monomers
(Fig. 1B, lane 2) and treatment with b-mercaptoethanol did
not aﬀect the monomer/tetramer ratio (not shown). Heated
hTTR dissociated mostly to a monomer, although some di-
meric species persisted (Fig. 1B, lane 3). Non-heated hTTR mi-
grated as a dimer (Fig. 1B, lane 4); treatment with b-
mercaptoethanol did not dissociate dimeric hTTR (not
shown).
These results indicate that hTTR dimer is more stable than
the TLP dimer. This instability was seen for both untagged
TLP and the FLAG derivative.-0.002
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Fig. 1. (A) TLP homotetramer. TLP analysed by gel ﬁltration shows a pea
standards ovalbumin (43 kDa) and ribonuclease A (13.7 kDa). (B) Tetramer s
and hTTR proteins. Lane 1: TLP boiled with b-mercaptoethanol; lane 2: T
mercaptoethanol; lane 4: hTTR not boiled, with b-mercaptoethanol. Omissio
D – dimer; M – monomer.2.2. Amyloidogenic properties
hTTR is able to form ﬁbrils in vitro upon acidiﬁcation
[19,20]. At low pH, hTTR tetramer dissociates into structurally
modiﬁed monomers, favouring aggregation and ﬁbril forma-
tion. hTTR ﬁbrils are mostly 8 nm wide, although 4–5 and
9–10 nm wide ﬁbrils can also be observed. With extended incu-
bation at low pH, hTTR ﬁbrils increase to 300 nm in length.
Sequence and structural similarities between TLP and hTTR
suggested that the ability to aggregate and form ﬁbrils might
be conserved between the two proteins. We therefore asked
if TLP could form amyloid under conditions other than those
used by Eneqvist et al. [17]. Consistent with previous reports,
TLP acidiﬁcation did not result in the thioﬂavin-T (Th-T)
binding characteristic of an amyloid fold (not shown; [17]).
A diﬀerent protocol for TLP ﬁbril formation was then tested,
which entailed incubating the protein at various pH values at
24 C with stirring (Fig. 2A, chart). At low pH (3.0 or 3.6)
no amyloid was formed. At higher pH values, however, (pH
4.8–6.8) an increase in ﬂuorescence intensity was observed
after Th-T addition, consistent with formation of amyloido-
genic TLP. Similar results were obtained with FLAG-tagged
TLP, i.e., amyloid formation was dependent on stirring at
pH 4.8–6.8. Thus, for convenience, we used FLAG-tagged
TLP in the following experiments to demonstrate and charac-
terize amyloid formation. TLP was incubated for 3 days at
24 C with stirring at pH 5.8 and then examined with cross
polarized light microscopy after Congo red binding12 14 16 18 20 22 24
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Fig. 2. TLP amyloid formation. (A) Th-T assay of TLP incubated with stirring at diﬀerent pH values at 24 C for 3 days. (B) Congo red staining of
TLP protein incubated for 3 days with stirring at pH 5.8, showing the characteristic green birefringence after visualization with polarized light (right
picture). (C) Dot blot ﬁlter assay of TLP immunostained with anti- FLAG antibody. (1) No protein; (2) soluble TLP; (3) TLP ﬁbrils. (D) Negative
staining of soluble TLP and TLP ﬁbrils induced with stirring at pH 5.8 for 3 days, visualized by TEM. The open arrow indicates a TLP ﬁbril of 8 nm
wide and the closed arrow a TLP annular structure with a diameter of 8 nm.
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yellow birefringence typical of amyloid.
We then performed a dot blot ﬁlter assay to conﬁrm the
aggregated state of TLP. A ﬁlter membrane retains aggregated
and ﬁbrillar protein, whereas soluble protein ﬂows through. As
shown by Western blot, TLP was retained on the ﬁlter only in
the Th-T positive form; soluble TLP passed through the ﬁlter
(Fig. 2C).
The appearance of TLP ﬁbrils was also monitored by trans-
mission electron microscopy (TEM). Prior to treatment, TLPis soluble (Fig. 2D, left picture). Following 3 days with stirring
at pH 5.8, aggregates are clearly visible (Fig. 2D, middle pic-
ture). Aggregates of diﬀerent types are seen: straight ﬁbrils
(open arrow), as well as twisted ﬁbrils and oligomers with
annular appearance (closed arrow). Both the diameter of olig-
omers and the width of ﬁbrils is around 8 nm.
2.3. TLP aggregate cytotoxicity
hTTR aggregates induce cellular toxicity [21] that contrib-
utes to familial amyloidotic polyneuropathy (FAP), a disease
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Fig. 3. Cytotoxicity of TLP amyloidogenic species. SH-SY5Y cells incubated with TLP aggregates show fewer live cells (green stained) and more
dead cells (red stained) as shown in the right panel of upper picture and middle chart, in comparison to controls without protein or with soluble TLP.
The live and dead cells were counted in three independent experiments, in duplicate and expressed as mean of live/dead cells with standard deviation.
Bottom chart shows the results of the caspase-3 assay performed in cells incubated with TLP. *P < 0.02; **P < 0.005.
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dogenic species were also cytotoxic. Native (soluble) or aggre-
gated TLP induced by stirring at pH 5.8 were incubated with a
human neuroblastoma cell line and the number of live and
dead cells determined. Treatment with native TLP had little ef-
fect on the ratio of live to dead cells. In contrast, exposure to
TLP aggregates signiﬁcantly decreased the number of live cells
with a concomitant increase in dead cells (Fig. 3, pictures and
top chart). These cells incubated with TLP aggregates present
caspase-3 activation as compared to cells incubated with the
native protein (Fig. 3, bottom chart). Another neuronal cell
line (ND7/23) shows also caspase-3 activation by addition of
TLP aggregates (not shown). We conclude that, TLP, like
hTTR, is cytotoxic when misfolded and aggregated.3. Discussion
While hTTR has long been characterized in terms of biol-
ogy, biochemistry and biophysics, the sequences homologousto TTR found in TLP proteins of lower eukaryotes and pro-
karyotes, have only recently been studied. The considerable se-
quence similarity to hTTR suggests common ligands; however,
as reported, TLP has no aﬃnity for thyroid hormones [17] a
hTTR ligand.
As described by Eneqvist et al. [17] E. coli TLP is a homotet-
rameric protein with a calculated molecular weight of 52 kDa.
The E. coli TLP used in our experiments also behaves as tetra-
mer with a molecular weight of approximately 52 kDa.We ana-
lysed dissociation of TLP tetramers and found similarities to
hTTR. Boiling the protein in SDS–PAGE buﬀer, which favours
hTTR monomerization, also induced TLP dissociation to a
monomer. In contrast, unheated hTTR runs as a dimer in
SDS–PAGE, whereas unheated TLP runs as a tetramer, indi-
cating that the dimer–dimer association of TLP is more stable.
TLP is mainly composed of b-sheets [22] and, as in hTTR,
this fold favours amyloidogenesis. In contrast to previous re-
ports, TLP is, in fact, amyloidogenic, as detected by positive
Th-T and Congo red binding. This was demonstrated using
a diﬀerent protocol with stirring at pH 5.8. Th-T positive
S.D. Santos et al. / FEBS Letters 582 (2008) 2893–2898 2897TLP aggregates of diﬀerent types, including straight ﬁbrils,
coiled ﬁbrils and oligomers, were observed by electron micros-
copy. The 8 nm width of TLP ﬁbrils was comparable to hTTR
ﬁbrils, suggesting that TLP ﬁbrils might also assemble by
monomer–monomer interactions.
TLP amyloidogenic species were tested for cytotoxicity by
incubating TLP Th-T positive preparations with a human neu-
roblastoma cell culture (SH-5YSY) previously used in toxicity
studies of amyloidogenic hTTR species. Exposure to modiﬁed
TLP drastically decreased cell viability, whereas soluble TLP
was much less toxic. The cellular death occurs through apop-
tosis with caspase-3 activation as it was determined in two dis-
tinct cell lines. This result conﬁrms the belief that in
conformational disorders an altered conformation of the pro-
tein that accumulates in tissues is responsible for compromis-
ing cell viability. Such is the case in FAP where the
homologous protein to TLP – the TTR protein – is only path-
ological when in an altered conformation. This result contrib-
utes to a better understanding of TTR cytotoxicity in FAP for
the structural point of view.
An interesting perspective on the relevance of TLP ﬁbril for-
mation is the possibility of a novel function resulting from the
altered conformation. Some studies reveal that amyloid forma-
tion is essential to the function of certain bacterial proteins
[23,24]. Such is the case of soluble bacterial microcin E492 pro-
tein which is cytotoxic to eukaryotic cells [25] by forming lethal
pores in eukaryotic cytoplasmic membranes, whereas the ﬁbril-
lar conformer is harmless [26].
In conclusion, TLP resembles hTTR in: (i) its homotetra-
meric structure, (ii) its monomerization by heat/SDS treat-
ment, (iii) the ability to form amyloidogenic species with a
similar appearance and dimensions as hTTR and (iv) the cyto-
toxicity of amyloidogenic species. Unlike hTTR, TLP does not
bind thyroid hormones [17]. Additionally, TLP, but not hTTR,
is involved in purine/pirimidine metabolism. TLP has a
hydroxyisourate hydrolase activity that converts uric acid to
allantoin [13,15]. Finally, the pI of TLP, 9.10, contrasts with
hTTR whose pI is 5.35.
Future studies are necessary to better understand the evolu-
tion of TLP and its role in prokaryotic physiology. In particu-
lar, we would like to know if TLP ﬁbrils are found in vivo and,
if so, whether such structures are functional.4. Materials and methods
4.1. Cloning and puriﬁcation of TLP with and without the FLAG tag
TLP was cloned with a FLAG tag at the C-terminus in a pET 3a vec-
tor (Novagen) in the Nde I and Hind III cloning sites. Primers were de-
signed as follows: sense primer 5 0-GGGAATTCCATATGGCACAAC
AAAACATTCTTAGCGT-3 0 and anti-sense primer 5 0-CGCGGAT
CCTCACTTGTCGTCATCGTCTTTGTAGTCACTGCCACGATA
GGTTGA-30. Cloned plasmids with the TLP were sequenced. Trans-
formation was performed in E. coli BL21 pLysS grown in LB. Induc-
tion was with IPTG at 30 C o/n. After cell lysis by freezing/thawing
and sonication, the supernatant was equilibrated with diethylaminoeth-
yl (DEAE)-cellulose (Whatman) in HEPES, pH 7.5/NaCl buﬀer. The
ﬂow-through with puriﬁed TLP was collected, dialyzed and concen-
trated.
The TLP preparation was analysed by matrix assisted laser desorp-
tion ionization mass spectrometry (MALDI-MS), in a Perspective
Voyager DE-RP mass spectrometer as a service by Protein Chemistry
Core Facility, Columbia University. Brieﬂy, the TLP band was excised
from a 15% SDS–PAGE gel, stained with Coomassie Brilliant Blue
and treated as in [27].TLP was analysed by gel ﬁltration in a Superose 12 column in Tris/
NaCl, pH 7.5 buﬀer. Protein standards used for calibration were:
hTTR (56 kDa), ovalbumin (43 kDa) and ribonuclease A (13.7 kDa).
TLP without the FLAG tag was cloned in pET101/D-TOPO with
the following primers: forward (5 0-CACCATGGCACAACAAAA
CATTCTTAGT-3 0) and reverse (5 0-TTAACTGCCACGATAGGTT-
GAAT 3 0). Protein production and puriﬁcation was performed in
BL21 star (DE3) grown in LB. Brieﬂy, bacterial lysates were applied
to a SP-sepharose column and eluted with a (NH4)2SO4 gradient
(0–500 mM). The pure TLP fractions were dialysed against Tris, pH
7.5.
4.2. TLP tetramer stability
TLP was analysed in a SDS–PAGE (15% acrylamide) after being
subjected to diﬀerent treatments: dilution in (1) 1· SDS buﬀer with
b-mercaptoethanol and boiling for 5 min; (2) 1· SDS buﬀer with b-
mercaptoethanol, without boiling; (3) 1· SDS buﬀer without b-
mercaptoethanol and boiling for 5 min and (4) 1· SDS buﬀer without
b-mercaptoethanol and without boiling. The gel was stained with Coo-
massie Brilliant Blue.
4.3. TLP ﬁbril formation
TLP with or without the FLAG tag was dialysed against H2O and
quantiﬁed (Bio-Rad protein assay). One milligram per milliliter of pro-
tein in 100 ll of 50 mM sodium acetate buﬀer at diﬀerent pH values
was used to produce ﬁbrils. The pH range was from 2.3 to 7.0 and
the solutions were incubated at 24 C for 72 h. TLP at a concentration
of 0.250 mg/ml in 50 mM sodium acetate buﬀer was stirred at 24 C,
for 72 h at pH 3.0, 3.4, 4.8, 5.8 or 6.8.
4.3.1. Th-T binding. Amyloidogenic material was identiﬁed by
binding to Th-T (Fluka) in 50 mM glycine buﬀer, pH 9.0. Excitation
spectra were recorded with a Jasco FP-770 spectroﬂuorometer to con-
ﬁrm amyloid-like properties with the characteristic excitation maxima
at 450 nm upon Th-T binding.
4.3.2. Congo red binding. Congo red birefringency was detected by
applying TLP ﬁbrils, induced by stirring for 3 days as described above,
on a slide followed by drying. Next, 0.2% Congo red solution was
added for 20 min followed by a wash with 20% ethanol. Slides were
mounted and visualized under polarized light.
4.3.3. Dot blot ﬁlter assay. Soluble (500 ng) and Th-T positive TLP
(100 ng) were applied to a 0.2 lm pore cellulose acetate membrane ﬁl-
ter (Schleicher & Schuell) which retains aggregated and ﬁbrillar mate-
rial but not soluble protein. A manifold system (Gibco BRL) under
vacuum was used. The ﬁlter was washed three times with PBS and pro-
cessed for TLP immunodetection with anti-FLAG antibody, as de-
scribed above. Detection was performed with Super Signal West
Pico (Pierce).
4.3.4. TEM. TLP ﬁbril formation was induced by stirring at pH 5.8
for 3 days and visualized with TEM by negative staining as follows:
proteins were adsorbed to glow-discharged carbon-coated collodion
ﬁlm supported on 200-mesh copper grids for 1 min. After washing with
H2O, samples were stained with a 0.75% uranyl acetate solution. Grids
were visualized with a Zeiss microscope operated at 60 kV. Measure-
ment of TLP ﬁbrillar width was made from photomicrographs using
a magnifying glass with a built-in calibrated rule.
4.4. Cell viability assay
Human neuroblastoma (SHSY-5Y) cell line was cultured with
F12:DMEM and 10% FBS in Lab-Tek slides (Nunc). Six hours before
the cell viability assay, cells were cultured with the same medium sup-
plemented with 1% FBS and soluble TLP or TLP amyloidogenic species
preparations at a ﬁnal concentration of 0.110 mg/ml. Cell viability was
measured with the live and dead assay (Molecular Probes) according to
manufacturers instructions. Brieﬂy, after washing the cells with PBS,
the ethidium–calcein mixture (0.5 and 1 mM, respectively) was added
and incubated for 30 min. Cells were then observed in a Zeiss Cell Ob-
server System microscope (Carl Zeiss, Germany) equipped with ﬁlters
for FITC and rhodamine-like dyes, and percentages of live (green-
stained) and dead (red-stained) cells were determined.
4.5. Caspase-3 assay
A human neuroblastoma (SH-SY5Y) cell line or the hybrid mouse/
rat neuroblastoma (ND7/23) cell line were cultured as described above
and treated with TLP overnight at a ﬁnal concentration of 0.110 mg/ml
2898 S.D. Santos et al. / FEBS Letters 582 (2008) 2893–2898in medium without FBS. Activation of caspase-3 was measured using
the ﬂuorometric caspase-3 assay kit (Sigma) following the manufac-
turers instructions. The remaining cell lysate was used to measure total
cellular protein concentration with the Bio-Rad protein assay kit,
using bovine serum albumin as standard. Values shown are the mean
of duplicates of caspase-3 data normalized with total protein concen-
tration and the experiment was performed three times.
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